Company / Current Liabilities per Share
Cullinan Therapeutics, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.52
FY2024
5-year range
$0.39 / $0.72
FY2020-FY2024
Trend
-22.7%
vs FY2023
Sector context
#153 of 210
Health Care
What the data says
At $0.52, Cullinan Therapeutics, Inc.'s current liabilities per share ranks #58 of 210 in the Health Care sector. Increased from $0.49 to $0.52 over the past 2 years.
Based on SEC 10-K filings.
0.52 in FY2024 with a 3-year CAGR of +10.0%.
Increased from $0.49 to $0.52 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +10.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#58 of 210 in Health CareTop 27% of 210This company $0.52 Sector average $23.79
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 22.7% year-over-year.
- Ranks #153 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.52 | -22.7% |
| FY2023 | $0.68 | +37.8% |
| FY2022 | $0.49 | +24.8% |
| FY2021 | $0.39 | -45.3% |
| FY2020 | $0.72 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026